GlassScriptPhysician profile
Frank C Bohnenkamp
NPI 1669647129
$29,817.24
in general payments reported to CMS, 2019-2025
12 companies · $5,816 in 2025
The $5,816 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,715 · 2020: $39.92 · 2021: $7,102 · 2022: $4,496 · 2023: $6,392 · 2024: $2,256 · 2025: $5,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,223 · Food and Beverage: $3,565 · Travel and Lodging: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,222.79 |
| Food and Beverage | $3,564.72 |
| Travel and Lodging | $1,676.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $18,599.21 | 2019-2025 | Velys, Attune |
| Smith+Nephew, INC. | $4,796.58 | 2019-2024 | Or3o Dual Mobility, Journey, Journey II |
| Depuy Synthes Sales INC. | $4,644.04 | 2019-2025 | Velys, Attune, Tfn-Advance |
| Kerecis Limited | $855.62 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $455.51 | 2019-2025 | Mako, Triathlon |
| Surgenex LLC | $170.13 | 2025 | Renograft, Pellograft, Surmatrix |
| Avanos Medical | $103.89 | 2024 | On-Q* Pump and Accessories |
| Dynasplint Systems INC. | $96.72 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $47.16 | 2025 | |
| Polynovo North America LLC | $18.04 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.93 | 2023 | Seglentis |
| Kci USA, INC. | $14.41 | 2023 | Prevena, Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Bohnenkamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.